Bracco Imaging and NYU Langone Health Form Multi-Year Research Alliance in Medical Imaging
Bracco Imaging has announced a strategic alliance with NYU Langone Health to advance innovation in medical imaging through a multi-year Master Research Agreement, announced in a press release.
The collaboration will focus on developing and optimizing technologies in Magnetic Resonance Imaging (MRI), Photon-Counting Computed Tomography (PCCT), targeted ultrasound, and artificial intelligence-enabled PET/CT and MRI image analysis. The goal is to enhance diagnostic performance, streamline clinical workflows, and improve patient management.
Joint research activities will combine NYU Langone Health’s clinical and academic expertise with Bracco Imaging’s experience in contrast imaging and diagnostic solutions. The agreement is structured to strengthen ties between research and clinical practice, supporting the translation of scientific findings into healthcare applications.
According to Bracco Imaging’s CEO Fulvio Renoldi Bracco and NYU Langone’s Chair of Radiology Michael P. Recht, the partnership reflects a shared effort to drive progress in precision medicine and diagnostic accuracy through advanced imaging and artificial intelligence.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Nov 13 ETR survey: Claude leads enterprise AI tools on satisfaction and spending plans Nov 13 Peter Sarlin's PostScriptum takes majority stake in Finnish AI deployment firm Brillian Nov 13 Gondola says Codex lifted engineering output 25% as revenue more than doubled Nov 13 DuPont teams with Microsoft and NobleAI to speed up R&D with AI Nov 13 Korean AI startups fear Huang exit could delay planned NVIDIA investmentsMore from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
Boehringer Ingelheim and Microsoft to Study Digital Patient Twins
Weill Cornell says patient data was entered into AI tools without authorisation for a radiology study
RADPAIR builds its AI radiology reporting into Novarad's NovaPACS imaging platform
NYU Langone's Lang1 beats much larger AI models at predicting hospital outcomes
Daily AI Brief: the AI news that matters, in your inbox.